Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

NCT05003752 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Radiation Toxicity

Interventions

RADIATION: External beam radiation therapy, High-dose-rate brachytherapy
DRUG: Goserelin 10.8 mg

Sponsor

German Oncology Center, Cyprus